NCT04491643View on ClinicalTrials.gov

Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

August 11, 2023

Study Completion Date

April 11, 2025

Conditions
Endometrial Carcinoma Stage I
Interventions
DRUG

Megestrol Acetate

At a dosage of 160 mg/day

DRUG

Rosuvastatin

At a dosage of 10 mg/day

Trial Locations (1)

Unknown

Obstetrics and Gynecology Hospital, Fudan University, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT04491643 - Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma | Biotech Hunter | Biotech Hunter